ES2187635T3 - Uso de inmunoglobulinas de clase g para el tratamiento topico de dermatitis atopica. - Google Patents

Uso de inmunoglobulinas de clase g para el tratamiento topico de dermatitis atopica.

Info

Publication number
ES2187635T3
ES2187635T3 ES96905988T ES96905988T ES2187635T3 ES 2187635 T3 ES2187635 T3 ES 2187635T3 ES 96905988 T ES96905988 T ES 96905988T ES 96905988 T ES96905988 T ES 96905988T ES 2187635 T3 ES2187635 T3 ES 2187635T3
Authority
ES
Spain
Prior art keywords
atopic dermatitis
topical treatment
dermatitis
immunoglobulins
class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96905988T
Other languages
English (en)
Other versions
ES2187635T5 (es
Inventor
Simone Claudio De
Pietro Bruschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VSL Pharma Ltd
Original Assignee
VSL Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11403139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2187635(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by VSL Pharma Ltd filed Critical VSL Pharma Ltd
Publication of ES2187635T3 publication Critical patent/ES2187635T3/es
Application granted granted Critical
Publication of ES2187635T5 publication Critical patent/ES2187635T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBE EL USO DE INMUNOGLOBULINAS DE CLASE G, EN PARTICULAR DE INMUNOGLOBULINAS PARA USO INTRAVENOSO (IVIG) O PARA USO INTRAMUSCULAR (IMIG), PARA PRODUCIR UNA MEDICINA PARA EL TRATAMIENTO TERAPEUTICO LOCAL DE DERMATITIS, EN PARTICULAR EL ACNE, LA DERMATITIS DE CONTACTO, LA DERMATITIS ATOPICA, EL ECCEMA Y LA ICTIOSIS, LA PSORIASIS, LAS DERMOPATIAS PAPULOSCAMOSAS (DERMATITIS SEBORREICA, ERITRODERMIA, ETC.), ASI COMO DERMATITIS POR INFECCION DE HONGOS, DE PARASITOS, DE BACTERIAS Y DE VIRUS, Y LA COMPOSICION FARMACEUTICA QUE LAS CONTIENE.
ES96905988T 1995-03-14 1996-03-12 Uso de inmunoglobulinas de clase g para el tratamiento topico de dermatitis atopica. Expired - Lifetime ES2187635T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95RM000154A IT1278052B1 (it) 1995-03-14 1995-03-14 Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per
ITRM95A0154 1995-03-14

Publications (2)

Publication Number Publication Date
ES2187635T3 true ES2187635T3 (es) 2003-06-16
ES2187635T5 ES2187635T5 (es) 2006-09-01

Family

ID=11403139

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96905988T Expired - Lifetime ES2187635T5 (es) 1995-03-14 1996-03-12 Uso de inmunoglobulinas de clase g para el tratamiento topico de dermatitis atopica.

Country Status (12)

Country Link
US (2) US6410019B1 (es)
EP (1) EP0814837B2 (es)
JP (1) JP3939346B2 (es)
KR (1) KR19980702515A (es)
AT (1) ATE228854T1 (es)
CA (1) CA2213500C (es)
DE (1) DE69625182T3 (es)
DK (1) DK0814837T4 (es)
ES (1) ES2187635T5 (es)
IT (1) IT1278052B1 (es)
PT (1) PT814837E (es)
WO (1) WO1996028186A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059428A1 (en) * 1993-02-26 2003-03-27 Boris Skurkovich Treatment of autoimmune diseases
US7297480B2 (en) * 2001-06-28 2007-11-20 Dermtech International Method for detection of melanoma
RU2235556C1 (ru) * 2003-02-13 2004-09-10 Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН Способ лечения атопического дерматита
US7183057B2 (en) * 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
WO2008137772A1 (en) * 2007-05-04 2008-11-13 Dermtech International Diagnosis of melanoma by nucleic acid analysis
BRPI0913578A2 (pt) 2008-05-14 2017-06-06 Dermtech Int diagnose de melanoma e lentigo solar por análise de ácido nucléico
US20100086501A1 (en) * 2008-08-28 2010-04-08 Dermtech International Determining Age Ranges of Skin Samples
WO2011130800A1 (en) * 2010-04-23 2011-10-27 Probiotec Limited Eczema treatment
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
AU2020247911A1 (en) 2019-03-26 2021-11-11 Dermtech, Llc Novel gene classifiers and uses thereof in skin cancers
US20240182552A1 (en) * 2021-04-07 2024-06-06 Ajou University Industry-Academic Cooperation Foundation Pharmaceutical composition for preventing or treating immune dysregulation-related diseases comprising oxidized immunoglobulin as active ingredient

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2610854A1 (de) * 1976-03-15 1977-09-22 Biotest Serum Institut Gmbh Galenische immunglobulinzubereitung
EP0127712B1 (en) * 1983-06-07 1989-01-11 The Stolle Research And Development Corporation Deodorant containing bacterial antibodies
US5141742A (en) * 1986-02-07 1992-08-25 Oncogen Vaccines against melanoma
ATE118350T1 (de) * 1988-07-22 1995-03-15 Morris John Co Inc Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung.
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
FR2669538B1 (fr) * 1990-11-28 1995-03-03 Fondation Nale Transfusion San Utilisation d'immunoglobulines administrees localement dans le traitement des infections epitheliales.
CA2153661A1 (en) 1993-01-12 1994-07-21 Anthony George Gristina Methods and compositions for the direct concentrated delivery of passive immunity
JP3193205B2 (ja) * 1993-08-09 2001-07-30 日本臓器製薬株式会社 好酸球増多抑制剤

Also Published As

Publication number Publication date
DK0814837T3 (da) 2003-03-31
DE69625182T2 (de) 2003-11-20
DE69625182T3 (de) 2006-08-24
CA2213500C (en) 2010-01-26
DK0814837T4 (da) 2006-05-29
ATE228854T1 (de) 2002-12-15
EP0814837B2 (en) 2006-02-22
JPH11501915A (ja) 1999-02-16
WO1996028186A1 (en) 1996-09-19
KR19980702515A (ko) 1998-07-15
US6410019B1 (en) 2002-06-25
PT814837E (pt) 2003-04-30
US7217416B2 (en) 2007-05-15
ITRM950154A1 (it) 1996-09-14
CA2213500A1 (en) 1996-09-19
EP0814837B1 (en) 2002-12-04
IT1278052B1 (it) 1997-11-17
EP0814837A1 (en) 1998-01-07
US20020192276A1 (en) 2002-12-19
ITRM950154A0 (it) 1995-03-14
JP3939346B2 (ja) 2007-07-04
DE69625182D1 (de) 2003-01-16
ES2187635T5 (es) 2006-09-01

Similar Documents

Publication Publication Date Title
ES2163504T3 (es) Formas de dosificacion de liberacion controlada de azitromicina.
ES2163090T3 (es) Uso de toxina botulinica para tratar la cefalea tensional.
MX9300766A (es) Piridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
NO991492L (no) FremgangsmÕte for Õ oppnÕ forbedret selektivitet ved fotoaktivering av molekylµre midler
BR0012195A (pt) Método para tratar câncer de próstata num ser humano, artigo de fabricação e uso de um anticorpo que liga erbb2
DK1071417T3 (da) Anvendelse af cannabidiol som anti-inflammatorisk middel
DK0946507T3 (da) Substituerede pyrrolylforbindelser til behandling af inflammation
DE69735634D1 (de) Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ES2138603T3 (es) Procedimiento para el aislamiento de los factores ix, x y ii altamente purificados a partir del complejo protrombinico o del plasma humano.
ES2046176T3 (es) Composicion farmaceutica que contiene una asociacion de colageno y de un principio activo antiseptico y/o antiinflamatorio y su procedimiento de fabricacion.
MX9301858A (es) Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv.
BR9707357A (pt) 2,4-Diamino-1,3,5-triazinas processo para a sua preparação e sua aplicação como herbicidas e reguladores do crescimento de plantas
DE59606324D1 (de) Kosmetische und dermatologische lichtschutzformulierungen in form von o/w-emulsionen
BR9506866A (pt) Composiçao biologicamente purificada composiçao para utilizaçao como um agente anti-inflamatório processo para o tratamento de mamíferos tendo tecido inflamado e processo para á produçao de ciclomarin-a
SE7803646L (sv) Salva for huddesinfektion och sett att framstella densamma
CY1105068T1 (el) ΈΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ ΓΙΑ Xa
DK0814837T3 (da) Anvendelse af G-klasse-immunoglobuliner til topikal behandling af atopisk dermatitis
DE69129693D1 (de) Verwendung von nickel und bromide ionen für die behandlung von psoriasis
DE69312948D1 (de) Verwendung von lectinen für die behandlung von krankheiten
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
ATE137406T1 (de) Zubereitung für die topische behandlung von infektionen durch viren, bakterien und schimmel
ES2151891T3 (es) Derivados de ciclohexano sustituidos con imidazolilo.
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
BR0204057A (pt) Processos para geração de terahertz